The recently described genus Pandoraea contains five named species (Pandora
ea apista, Pandoraea pulmonicola, Pandoraea pnomenusa, Pandoraea sputorum,
and Pandoraea norimbergensis) and four unnamed genomospecies. Pandoraea spp
. have mainly been recovered from the respiratory tracts of cystic fibrosis
(CF) patients. Accurate genus- and species-level identification by routine
clinical microbiology methods is difficult, and differentiation from Burkh
olderia cepacia complex organisms may be especially problematic. This can h
ave important consequences for the management of CF patients. On the basis
of 16S ribosomal DNA sequences, PCR assays for the identification of Pandor
aea spp. were developed. A first PCR assay was developed for the identifica
tion of Pandoraea isolates to the genus level. PCR assays for the identific
ation of P. apista and P. pulmonicola as a group, A pnomenusa, A sputorum,
and A norimbergensis were also developed. All five assays were evaluated wi
th a panel of 123 bacterial isolates that included 69 Pandoraea sp. strains
, 24 B. cepacia complex strains, 6 Burkholderia gladioli strains, 9 Ralston
ia sp. strains, 5 Alcaligenes Xylosoxidans strains, 5 Stenotrophomonas malt
ophilia strains, and 5 Pseudomonas aeruginosa strains. The use of these PCR
assays facilitates the identification of Pandoraea spp. and avoids the mis
identification of a Pandoraea sp. as a B. cepacia complex isolate.